9 May 2014

More Effective Vaccines Thanks to a Needleless Injector

A Québec team of researchers collaborating with Professor Martin Brouillette from the Université de Sherbrooke will work on developing and manufacturing innovative vaccines against respiratory viruses such as influenza.

3802302836-injecteur_sans_aiguille_brouilletteThe project, made possible through a $12.3 million grant from the ministère des Finances et de l’Économie and the company Medicago, aims to develop a method of administration and formulation that will increase the vaccines’ efficiency, especially among the elderly.

Professor Brouillette will focus on how to administer vaccines using the needleless injector he designed.

The new vaccines to be developed will take advantage of the virus-like particles (VLP) developed by Medicago. They consist in plant-based products that stimulate immune response.

The interuniversity project is co-directed by the Research Institute of the McGill University Health Centre (RI-MUHC) and the CHUQ, in collaboration with the Université de Sherbrooke, Université Laval, and McGill University.

Source: Université de Sherbrooke
Photo credit: Michel Caron

Back to the news

Leave a Reply

Your email address will not be published. Required fields are marked *

Sherbrooke Innopole’s mandate ends on March 31, 2024. We invite you to contact Entreprendre Sherbrooke or the Service du développement économique of the Ville de Sherbrooke for further services.
Thank you to all Sherbrooke industrial and technological businesses, as well as to all our partners for the trust granted since 2009!